Heidi W. Moore
Heidi W. Moore is a NYC-based writer and editor of multimedia, digital, and print content for professional and consumer audiences. Her portfolio includes health, wellness, and medical topics with occasional forays into fashion and finance.
Do TNFis Reduce the Risk for Progression to PsA in Patients With Psoriasis?
Researchers evaluated the use of TNFis vs methotrexate in reducing the risk for progression to psoriatic arthritis in patients with psoriasis.
Registries Established for Patients With Psoriasis, Atopic Dermatitis, and COVID-19
New registries have been established to capture emerging data on patients with psoriasis and atopic dermatitis who have COVID-19.
Biologic, Immunosuppressive Therapies Not Tied to Severe Outcomes From COVID-19 Infection
A study from Italy reports severe outcomes related to the COVID-19 infection in patients with chronic plaque psoriasis receiving immunosuppressive therapies.
Assessing Use of Biologic Agents for Psoriasis Amidst COVID-19
In the absence of COVID-19-specific data, published research may serve to guide treatment with biologic agents in patients with psoriasis.
Secukinumab Provides Sustained Improvement in Nail Psoriasis
Researchers reported on the efficacy of secukinumab in patients with psoriatic arthritis and nail psoriasis and other elements of the disease, including radiographic progression.
Interleukin-23 Blocker Risankizumab Promising for Psoriasis
In this first report of a head-to-head trial comparing risankizumab and adalimumab, the former agent was found to demonstrate greater efficacy in patients with moderate to severe plaque psoriasis.